Extension of CMV prophylaxis possible after allogeneic stem cell transplantation

被引：0
|
作者：
Freyer, Martina
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：162 / 162
页数：1
相关论文
共 50 条
  • [21] Foscarnet -: an alternative for cytomegalovirus prophylaxis after allogeneic stem cell transplantation?
    Ordemann, R
    Naumann, R
    Geissler, G
    Kroschinsky, F
    Bornhäuser, M
    Schwerdtfeger, R
    Ehninger, G
    ANNALS OF HEMATOLOGY, 2000, 79 (08) : 432 - 436
  • [22] Foscarnet – an alternative for cytomegalovirus prophylaxis after allogeneic stem cell transplantation?
    R. Ordemann
    R. Naumann
    G. Geißler
    F. Kroschinsky
    M. Bornhäuser
    R. Schwerdtfeger
    G. Ehninger
    Annals of Hematology, 2000, 79 : 432 - 436
  • [23] Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation
    Mousset, S.
    Bug, G.
    Heinz, W. J.
    Tintelnot, K.
    Rickerts, V.
    TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (03) : 261 - 264
  • [24] Delayed ABLC prophylaxis after allogeneic stem-cell transplantation
    Jansen, Jan
    Akard, Luke P.
    Wack, Matthew F.
    Thompson, James M.
    Dugan, Michael J.
    Leslie, Jill K.
    Mattison, Reid
    MYCOSES, 2006, 49 (05) : 397 - 404
  • [25] Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation
    Mendorf, Alexander
    Klyuchnikov, Evgeny
    Langebrake, Claudia
    Rohde, Holger
    Ayuk, Francis
    Regier, Marc
    Christopeit, Maximilian
    Zabelina, Tatjana
    Bacher, Adelbert
    Stuebig, Thomas
    Wolschke, Christine
    Bacher, Ulrike
    Kroeger, Nicolaus
    ACTA HAEMATOLOGICA, 2015, 134 (03) : 146 - 154
  • [26] An unusual pattern of B-cell immunological reconstitution after allogeneic stem cell transplantation: A possible correlation with CMV reactivation?
    Di Martino, Daniela
    Terranova, M. Paola
    Valetto, Angelo
    Scarso, Lucia
    Faraci, Maura
    Lanino, Edoardo
    Morreale, Giuseppe
    PEDIATRIC TRANSPLANTATION, 2009, 13 (08) : 1050 - 1052
  • [27] Donor and recipient CMV status and the risk of CMV activation after allogeneic stem cell transplantation.
    Juvonen, E
    Ruutu, T
    Eriksson, B
    Remes, K
    Volin, L
    Remberger, M
    Parkkali, T
    Hägglund, H
    Ringdén, O
    BLOOD, 2001, 98 (11) : 396A - 396A
  • [28] Risk Factors for Progression of CMV Viremia to CMV Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Mack, Johnathan P.
    Tan, Xianming
    Vinh, Donald C.
    Popradi, Gizelle
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S296 - S297
  • [29] Incidence of CMV replication and the role of letermovir primary/secondary prophylaxis in the early phase after allogeneic hematopoietic stem cell transplantation
    Studer, U.
    Medinger, M.
    Khanna, N.
    Leuzinger, K.
    Hirsch, H.
    Heim, D.
    Lengerke, C.
    Tsakiris, D.
    Halter, J.
    Gerull, S.
    Passweg, J.
    Gwerder, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 198 - 199
  • [30] How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation
    Einsele, Hermann
    Ljungman, Per
    Boeckh, Michael
    BLOOD, 2020, 135 (19) : 1619 - 1629
12345